126 related articles for article (PubMed ID: 8770771)
1. Modulation of tumor-associated antigen expression on human pancreatic and prostate carcinoma cells in vitro by alpha- and gamma-interferons.
Sivinski CL; Lindner DJ; Borden EC; Tempero MA
J Immunother Emphasis Tumor Immunol; 1995 Oct; 18(3):156-65. PubMed ID: 8770771
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons.
Tran R; Hand PH; Greiner JW; Pestka S; Schlom J
J Interferon Res; 1988 Feb; 8(1):75-88. PubMed ID: 3130426
[TBL] [Abstract][Full Text] [Related]
3. Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells.
Guadagni F; Schlom J; Johnston WW; Szpak CA; Goldstein D; Smalley R; Simpson JF; Borden EC; Pestka S; Greiner JW
J Natl Cancer Inst; 1989 Apr; 81(7):502-12. PubMed ID: 2466127
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment.
Greiner JW; Hand PH; Noguchi P; Fisher PB; Pestka S; Schlom J
Cancer Res; 1984 Aug; 44(8):3208-14. PubMed ID: 6744259
[TBL] [Abstract][Full Text] [Related]
5. Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma.
Brouwers AH; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
Cancer Biother Radiopharm; 2003 Aug; 18(4):539-47. PubMed ID: 14503948
[TBL] [Abstract][Full Text] [Related]
6. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens.
Wroblewski JM; Bixby DL; Borowski C; Yannelli JR
Lung Cancer; 2001; 33(2-3):181-94. PubMed ID: 11551413
[TBL] [Abstract][Full Text] [Related]
8. Effects of interferon gamma on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell lines.
Möbus VJ; Asphal W; Knapstein PG; Kreienberg R
J Cancer Res Clin Oncol; 1993; 120(1-2):27-34. PubMed ID: 8270604
[TBL] [Abstract][Full Text] [Related]
9. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
[TBL] [Abstract][Full Text] [Related]
11. Differential responsiveness of cloned mammary carcinoma cell populations to the human recombinant leukocyte interferon enhancement of tumor antigen expression.
Greiner JW; Tobi M; Fisher PB; Langer JA; Pestka S
Int J Cancer; 1985 Aug; 36(2):159-66. PubMed ID: 3160671
[TBL] [Abstract][Full Text] [Related]
12. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma.
Guadagni F; Witt PL; Robbins PF; Schlom J; Greiner JW
Cancer Res; 1990 Oct; 50(19):6248-55. PubMed ID: 2119252
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo regulation of tumor antigen expression by human recombinant interferons.
Guadagni F; Schlom J; Greiner JW
Int J Rad Appl Instrum B; 1991; 18(4):409-12. PubMed ID: 1907601
[TBL] [Abstract][Full Text] [Related]
14. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
[TBL] [Abstract][Full Text] [Related]
15. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
[TBL] [Abstract][Full Text] [Related]
17. Influence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression.
Flieger D; Hoff AS; Sauerbruch T; Schmidt-Wolf IG
Clin Exp Immunol; 2001 Jan; 123(1):9-14. PubMed ID: 11167991
[TBL] [Abstract][Full Text] [Related]
18. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
[TBL] [Abstract][Full Text] [Related]
19. Modulation of associated ovarian carcinoma antigens by 5 cytokines used as single agents or in combination.
Imbert-Marcille BM; Thédrez P; Saï-Maurel C; François C; Auget JL; Benard J; Jacques Y; Imai S; Chatal JF
Int J Cancer; 1994 May; 57(3):392-8. PubMed ID: 8169001
[TBL] [Abstract][Full Text] [Related]
20. Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype.
Krasagakis K; Garbe C; Krüger S; Orfanos CE
J Invest Dermatol; 1991 Aug; 97(2):364-72. PubMed ID: 1712824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
